Castle Biosciences logo
Castle Biosciences CSTL
$ 29.1 2.28%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Castle Biosciences Income Statement 2011-2024 | CSTL

Annual Income Statement Castle Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

656 M 660 M 1.08 B 1.27 B 258 M - - - - - - - -

Shares

26.8 M 26.1 M 25.1 M 18.9 M 8.58 M - - - - - - - -

Historical Prices

24.5 25.4 42.9 67.2 34.4 - - - - - - - -

Net Income

-57.5 M -67.1 M -31.3 M -10.3 M 5.28 M -6.37 M -12.4 M - - - - - -

Revenue

220 M 137 M 94.1 M 62.6 M 51.9 M 22.8 M 13.8 M - - - - - -

Cost of Revenue

45 M 32 M 15.8 M 9.68 M 7.31 M 5.3 M - - - - - - -

Gross Profit

- - - 53 M 44.6 M 17.5 M 8.83 M - - - - - -

Operating Income

-68 M -72.9 M -40.1 M -6.54 M 7.33 M -3.84 M - - - - - - -

Interest Expense

11 K 17 K 1 K 2.63 M 4.57 M 2.27 M - - - - - - -

EBITDA

-55.6 M -62.3 M -36.7 M -6.07 M 7.69 M -3.51 M -10.6 M - - - - - -

Operating Expenses

- - - 59.5 M 37.2 M 21.3 M 19.7 M - - - - - -

General and Administrative Expenses

180 M 143 M 86.7 M 48.1 M 29.8 M 16.5 M 15.3 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Castle Biosciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

27.8 M 27.6 M 27.5 M 27.4 M 26.8 M 26.7 M 26.6 M 26.6 M 26.3 M 26.1 M 25.4 M 25.4 M 25.3 M 25.1 M 24.9 M 24.8 M 19.9 M 17.5 M 17.4 M 17.1 M 12.8 M 2.15 M 1.92 M 1.92 M 1.91 M 1.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

2.27 M 8.92 M -2.53 M - -6.9 M -18.8 M -29.2 M - -20.2 M -1.65 M -24.6 M - -11.8 M -8.79 M -4.28 M -4.89 M -4.59 M -1.38 M 570 K 2.06 M 5.85 M -1.27 M -1.36 M 3.87 M -3.45 M -3.16 M -3.63 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

85.8 M 87 M 73 M - 61.5 M 50.1 M 42 M - 37 M 34.8 M 26.9 M - 23.5 M 22.8 M 22.8 M 17.3 M 15.2 M 12.7 M 17.4 M 17.6 M 14.8 M 10.7 M 8.72 M 11.4 M 3.71 M 3.98 M 3.66 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

15.6 M 14.5 M 13.9 M - 11.3 M 11.1 M 10.2 M - 8.86 M 7.69 M 5.94 M - 4.5 M 3.7 M 3.03 M - 2.48 M 2.15 M 2.39 M - 1.71 M 1.99 M 1.6 M - 1.35 M 1.33 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - 19.8 M 14.6 M 12.7 M 10.6 M 15 M 15.6 M 13.1 M 8.75 M 7.12 M 10.1 M 2.36 M 2.65 M 2.41 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

5.08 M 5.01 M -5.47 M - -9.64 M -21.2 M -31.5 M - -21.5 M -3.97 M -24.5 M - -11.8 M -8.81 M -4.28 M - -3.9 M -645 K 1.04 M - 4.43 M 608 K -322 K - -2.85 M -2.67 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

192 K 216 K 14 K - 2 K 3 K 4 K - 6 K 4 K 3 K - - - - - 706 K 769 K 764 K - 1.09 M 1.69 M 1.02 M - 569 K 525 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

6.35 M 6.11 M -2.13 M - -8.74 M -20.4 M -28.6 M - -20.9 M -3.44 M -22.4 M - -9.86 M -7.94 M -4.05 M - -3.59 M -452 K 1.13 M - 4.52 M 694 K -245 K - -2.78 M -2.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - - - - 24.1 M - - - 14 M - 8.64 M 8.14 M 7.44 M - 5.21 M 5.32 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

50.5 M 51.1 M 48.5 M - 44.6 M 44.7 M 46.8 M - 36.6 M 37.5 M 30.5 M - 22.6 M 20.8 M 18.2 M - 11.7 M 10.4 M 11.1 M - 7.12 M 6.82 M 6.05 M - 3.92 M 4.16 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency